<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Allergy</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Allergy</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский Аллергологический Журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1810-8830</issn><issn publication-format="electronic">2686-682X</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">446</article-id><article-id pub-id-type="doi">10.36691/RJA446</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">IgE-AB to animals molecular allergens in patients with respiratory allergy</article-title><trans-title-group xml:lang="ru"><trans-title>IgE-антитела к молекулярным аллергенным компонентам домашних животных у больных с респираторной аллергией</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Mokronosova</surname><given-names>M A</given-names></name><name xml:lang="ru"><surname>Мокроносова</surname><given-names>М А</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Bass</surname><given-names>E A</given-names></name><name xml:lang="ru"><surname>Басс</surname><given-names>Е А</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Bala</surname><given-names>A M</given-names></name><name xml:lang="ru"><surname>Бала</surname><given-names>А М</given-names></name></name-alternatives><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zheltikova</surname><given-names>T M</given-names></name><name xml:lang="ru"><surname>Желтикова</surname><given-names>Татьяна Михайловна</given-names></name></name-alternatives><email>t-zheltikova@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Mechnikov’s Research Institute for Vaccines and Sera, Russian Academy of Medical Sciences</institution></aff><aff><institution xml:lang="ru">ФГБУ «НИИ вакцин и сывороток им. И.И. Мечникова»</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Helix Laboratory Service</institution></aff><aff><institution xml:lang="ru">Лабораторная служба Хеликс</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2015-04-15" publication-format="electronic"><day>15</day><month>04</month><year>2015</year></pub-date><volume>12</volume><issue>2</issue><issue-title xml:lang="en">NO2 (2015)</issue-title><issue-title xml:lang="ru">№2 (2015)</issue-title><fpage>25</fpage><lpage>28</lpage><history><date date-type="received" iso-8601-date="2020-03-10"><day>10</day><month>03</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2015, Pharmarus Print Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2015, Фармарус Принт Медиа</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="en">Pharmarus Print Media</copyright-holder><copyright-holder xml:lang="ru">Фармарус Принт Медиа</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2017-12-15"/></permissions><self-uri xlink:href="https://rusalljournal.ru/raj/article/view/446">https://rusalljournal.ru/raj/article/view/446</self-uri><abstract xml:lang="en"><p>Background. The purpose of this study was to identify IgE-antibodies to the major and minor allergenic components of pets in the blood serum of patients with bronchial asthma and/or allergic rhinitis (BA/AR). Methods. The study included 327 patients from Moscow and St. Petersburg. All of them were detected for specific IgE-antibodies (IgE-AB) to the animal allergens by ImmunoCAP® (ThermoFisherScientific, Sweden). 105 patients wanted to detect IgE-AB to the main animal allergens molecules ImmunoCAP ISAC® (ThermoFisherScientific, Sweden). Results. In the sera of 327 patients IgE-AB to cat’s (62%) allergen dominated. IgE-antibodies to dog’s, house dust mites (D.pteronyssinus, D. farinae), mold fungi, horses and rodents allergens were found in 2,6-31 times less. IgE-AB to uteroglobin (rFel d 1), major cat allergen, was detected in 80% of patients (84/105). The detection rate of IgE-AB to other cat allergens was 4,2-8 times lower (rFel d 2 - 10%, nFel d 4 - 19%). IgE-AB to major dog allergen rCan f 1 was detected in 39% of patients (41/105). Positive level of IgE-AB to other dog allergens was detected in 2,2-4,9 times lower (rCan f 2 - 8%, nCan f 3 - 9%, rCan f 5 - 18%). Positive level of IgE-AB to lipocalin was assayed in 6% of patients, to serum albumin - in 7%. Conclusion. Prevalence of IgE-AB to cat and dog allergens was almost 3 times higher than the frequency of detection of IgE-AB to house dust mite allergens in citizens of Moscow and S. Petersburg. The frequency of IgE-AB to rFel d 1 was dominated and detected 2 and 4-11 times often than to rCan f 1 and other animal allergens consequently.</p></abstract><trans-abstract xml:lang="ru"><p>Цель исследования. Выявить IgE-AT к мажорным и минорным аллергенным компонентам домашних животных в сыворотках крови больных бронхиальной астмой и/или аллергическим ринитом (БА/АР). Материалы и методы. В исследование были включены 327 пациентов из Москвы и Санкт-Петербурга. У них было проведено выявление специфических IgE антител (IgE-АТ) к аллергенным экстрактам аллергенов животных с помощью ImmunoCAP (Thermo Fisher Scientific, Sweden). Из 327 пациентов 105 выразили желание определить специфические IgE-АТ к главным молекулам аллергенов животных с помощью ImmunoCAP ISAC® (Thermo Fisher Scientific, Sweden). Результаты. В сыворотках 327 пациентов доминировали IgE-АТ к аллергенам кошки (62%). IgE-АТ к аллергенам собаки, клещей домашней пыли (D. pteronyssinus, D. farinae), плесневых грибов, лошади и грызунов выявлены в 2,6-31 раз реже. У 105 из 327 пациентов изучали IgE-AT к молекулярным компонентам животных. У 80% (84/105) выявлены IgE-АТ к утероглобину (rFel d 1) - основному аллергену кошек. Частота выявления IgE-АТ к другим аллергенам кошки была в 4,2-8 раз ниже (rFel d 2 - 10%, nFel d 4 - 19%). IgE-АТ к основному аллергену собак rCan f 1 были выявлены у 39% пациентов (41/105). Положительный уровень IgE-АТ к другим аллергенам собаки был выявлен в 2,2-4,9 раза реже (rCan f 2 в 8%, nCan f 3 - 9%, rCan f 5 - 18%). Положительный уровень IgE-AT к липокалинам был выявлен у 6% пациентов, к сывороточным альбуминам - у 7%. Заключение. Полученные результаты свидетельствуют о том, что частота выявления IgE-АТ к аллергенам кошки и собаки примерно в 3 раза превышает частоту выявления IgE-АТ к аллергенам клещей домашней пыли. Доминируют IgE-AT к Fel d 1, которые выявляли в 2 (95% ДИ 1,6-2,6) раза чаще, чем к Can f 1, и в 4-11 раз чаще, чем IgE-AT к другим молекулам аллергенов животного происхождения.</p></trans-abstract><kwd-group xml:lang="en"><kwd>animal allergens</kwd><kwd>molecular diagnostics</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>аллергены животных</kwd><kwd>молекулярная диагностика</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Melen E., Wickman M., Nordvall S.L. Influence of early and current environmental exposure factors on sensitization and outcome of asthma in pre-school children. Allergy. 2001, v. 56, p. 646-652.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Surdu S., Montoya L.D., Tarbell A. Childhood asthma and indoor allergens in Native Americans in New York. Environmental Health: A Global Access Science Source. 2006, v. 5, p. 22.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Munthe-Kaas M.C., Bertelsen R.J., Torjussen T.M. et al. Pet keeping and tobacco exposure influence CD14 methylation in childhood. Pediatr. Allergy Immunol. 2012, v. 23, p. 747-754.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Nicolaou N., Yiallouros P., Pipis S. et al. Domestic allergen and endotoxin exposure and allergic sensitization in Cyprus. Pediatr. Allergy Immunol. 2006, v. 17, p. 17-21.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Ronmark E., Bjerg A., Perzanowski M. et al. Major increase in allergic sensitization in school children from 1996 to 2006 in Northern Sweden. J. Allergy Clin. Immunol. 2009, v. 124, p. 357-363.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Gusareva E.S., Bragina E.J., Deeva E.V. et al. Cat is a major allergen in patients with asthma from west Siberia. Allergy. 2006, v. 61, p. 509-510.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Огородова Л.М., Камалтынова Е.М., Деев И.А. и соавт. Эпидемиология аллергического ринита у детей Томска и сельской местности Томской области. Вестник оториноларингологии. 2010, № 3, c. 19-23.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>AWAO-ARIA-GA2LEN consensus document on molecular-based allergy diagnostics. World Allergy Organization Journal. 2013, v. 6, р. 17.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Nilsson O.B., Binnmyr J., Zoltowska A. et al. Characterization of the dog lipocalin allergen Can f 6: the role in cross-reactivity with cat and horse. Allergy. 2012, v. 67, p. 751-757.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Желтикова Т.М., Мокроносова М.А. Распространение клещей абарно-зернового комплекса и их роль в сенсибилизации жителей г. Москвы. Бюлл. эксп. биологии и мед. 1991, № 4, с. 396-398.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Gent J.F., Belanger K., Triche E.W. et al. Association of pediatric asthma severity with exposure to common household dust allergens. Environ. Res. 2009, v. 109, p. 768-774.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Larenas-Linnemann D., Michels A., Dinger H. et al. Allergen sensitization linked to climate and age, not to intermittent-persistent rhinitis in a cross-sectional cohort study in the (sub) tropics. Clin. Transl. Allergy. 2014, v. 4, p. 20-30.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Sanchez J., Diez S., Cardona R. Frequency of sensitization to animals in a tropical area. Rev. Allerg. Mex. 2014, v. 61, p. 81-89.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Nordlund B., Konradsen J.R., Kull I. IgE antibodies to animal-derived lipocalin, kallikrein and secretoglobin are markers of bronchial inflammation in severe childhood asthma. Allergy. 2012, v. 67, p. 661-669.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Gulbahar O., Sin A., Mete N. et al. Sensitization to cat allergens in non-cat owner patients with respiratory allergy. Ann. Allergy Asthma Immunol. 2003, v. 90, p. 635-639.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Kelly L.A., Erwin E.A., Platts-Mills T.A. The indoor air and asthma: the role of cat allergens. Curr. Opin. Pulm. Med. 2012, v. 18, p. 29-34.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Morgenstern J.P., Griffith I.J., Brauer A.W. et al. Amino acid sequence of Fel d 1, the major allergen of the domestic cat: Protein sequence analysis and cDNA cloning. Proc. Natl. Acad. Sci. USA. 1991, v. 88, p. 9690-9694.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Schmitz N., Dietmeier K., Bauer M. et al. Displaying Fel d 1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy. J. Exp. Med. 2009, v. 206, p. 1941-1955.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Emara M., Royer P.J., Abbas Z. et al. Recognition of the major cat allergen Fel d 1 through the cysteine-rich domain of the mannose receptor determines its allergenicity. J. Biol. Chem. 2011, v. 286, p. 13033-13040.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Gronlund H., Saarne T., Gafvelin G., van Hage M. The major cat allergen, Fel d 1, in diagnosis and therapy. International Archives of Allergy and Immunology. 2010, v. 151, p. 265-274.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Abramson S.L., Turner-Henson A., Anderson L. et al. Allergens in school settings: results of environmental assessments in 3 city school systems. J. School Health. 2006, v. 76, p. 246-249.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Permaul P., Hoffman E.B., Fu C. et al. Allergens in urban schools and homes of children with asthma. Pediatr. Allergy Immunol. 2012, v. 23, p. 543-549.</mixed-citation></ref></ref-list></back></article>
